714166864	714166864	CD	B-NP	O
|	|	NN	I-NP	O
THMH	THMH	NN	I-NP	O
|	|	NN	I-NP	O
00813648	00813648	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5085088	5085088	CD	B-NP	O
|	|	CC	I-NP	O
4/30/2005	4/30/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CHANGE	CHANGE	NNP	I-NP	I-protein
IN	IN	NNP	I-NP	I-protein
MENTAL	MENTAL	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
|	|	NNP	I-NP	O
Unsigned	Unsigned	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/30/2005	4/30/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Unsigned	Unsigned	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/4/2005	1/4/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
CASTONGVAY	CASTONGVAY	NNP	B-NP	O
,	,	,	O	O
JERALD	JERALD	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Change	Change	NN	B-NP	O
in	in	IN	B-PP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

ASSOCIATED	ASSOCIATED	VBN	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Urinary	Urinary	JJ	B-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
83-year-old	83-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
insulin-dependent	insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
carcinoid	carcinoid	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
weakness	weakness	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
son	son	NN	I-NP	O
found	find	VBD	B-VP	O
her	her	PRP	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
stated	state	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
fell	fall	VBD	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
weakness	weakness	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
weakness	weakness	NN	I-NP	O
and	and	CC	I-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
had	have	VBD	B-VP	O
lasted	last	VBN	I-VP	O
approximately	approximately	RB	B-NP	O
one	one	CD	I-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
dysuria	dysuria	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
nausea	nausea	NN	I-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
diarrhea	diarrhea	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
baseline	baseline	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
alert	alert	JJ	B-NP	O
and	and	CC	I-NP	O
oriented	orient	VBN	I-NP	O
x3	x3	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
lives	live	VBZ	B-VP	O
alone	alone	RB	B-ADVP	O
and	and	CC	O	O
functions	function	VBZ	B-VP	O
independently	independently	RB	B-ADVP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
CAT	CAT	NN	I-NP	B-protein
scan	scan	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
head	head	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
acute	acute	JJ	B-NP	O
process	process	NN	I-NP	O
.	.	.	O	O

Troponin	Troponin	NN	B-NP	B-protein
was	be	VBD	B-VP	O
0.2	0.2	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
therefore	therefore	RB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
IV	IV	CD	B-NP	O
heparin	heparin	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	B-protein
97.1	97.1	CD	I-NP	I-protein
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
78	78	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
190/82	190/82	CD	I-NP	O
,	,	,	I-NP	O
respiratory	respiratory	JJ	I-NP	O
rate	rate	NN	I-NP	O
18	18	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
oxygen	oxygen	NN	B-NP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

General	General	NNP	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
,	,	,	O	O
alert	alert	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
oriented	orient	VBD	B-VP	O
only	only	RB	B-NP	O
x1	x1	NN	I-NP	O
to	to	TO	B-PP	O
person	person	NN	B-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
NC/AT	NC/AT	NN	B-NP	B-protein
.	.	.	O	O

Neck	Neck	NNP	B-NP	O
:	:	:	O	O
Supple	Supple	NNP	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
Normal	Normal	JJ	B-NP	O
S1	S1	NN	I-NP	O
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
.	.	.	O	O

Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	O	O
rubs	rub	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
gallops	gallop	NNS	B-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
was	be	VBD	B-VP	O
soft	soft	JJ	B-ADJP	O
,	,	,	O	O
nontender	nontender	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
nondistended	nondistended	JJ	B-ADJP	O
,	,	,	O	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
bowel	bowel	NN	B-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
edema	edema	NN	I-NP	O
or	or	CC	I-NP	O
cyanosis	cyanosis	NN	I-NP	O
:	:	:	O	O
Neuro	Neuro	NN	B-NP	O
exam	exam	NN	I-NP	O
:	:	:	O	O
Strength	Strength	NN	B-NP	O
was	be	VBD	B-VP	O
equal	equal	JJ	B-ADJP	O
bilaterally	bilaterally	RB	B-ADVP	O
,	,	,	O	O
but	but	CC	O	O
weak	weak	JJ	B-NP	O
3/5	3/5	CD	I-NP	O
throughout	throughout	IN	B-ADVP	O
.	.	.	O	O

Sensation	Sensation	NN	B-NP	O
was	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
throughout	throughout	IN	B-ADVP	O
.	.	.	O	O

Cranial	Cranial	NNP	B-NP	O
nerves	nerve	VBZ	B-VP	O
III	III	CD	B-NP	O
through	through	IN	B-PP	O
XII	XII	NN	B-NP	B-DNA
were	be	VBD	B-VP	O
grossly	grossly	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Labs	Lab	NNS	B-NP	B-protein
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
12.3	12.3	NN	B-NP	B-protein
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
was	be	VBD	B-VP	I-protein
36.4	36.4	CD	B-NP	I-protein
,	,	,	O	O
CK	CK	NN	B-NP	O
of	of	IN	B-PP	O
3499	3499	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
troponin	troponin	NN	B-NP	O
of	of	IN	B-PP	O
0.2	0.2	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
was	be	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
new	new	JJ	B-NP	O
1	1	CD	I-NP	O
mm	mm	NN	I-NP	O
ST	ST	NN	I-NP	O
depression	depression	NN	I-NP	O
in	in	IN	B-PP	O
leads	lead	NNS	B-NP	O
II	II	CD	I-NP	O
,	,	,	I-NP	O
III	III	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
aVF	aVF	NN	B-NP	B-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
showed	show	VBD	B-VP	O
right	right	RB	B-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
mass	mass	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
previous	previous	JJ	I-NP	O
x-ray	x-ray	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
head	head	NN	I-NP	O
CT	CT	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Urinalysis	Urinalysis	NN	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
showed	show	VBD	B-VP	O
too	too	RB	B-ADJP	O
numerous	numerous	JJ	I-ADJP	O
to	to	TO	B-VP	O
count	count	VB	I-VP	O
white	white	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
plus	plus	CC	O	O
nitrates	nitrate	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
plus	plus	CC	O	O
leukocyte	leukocyte	NN	B-NP	B-protein
esterase	esterase	NN	I-NP	I-protein
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
83-year-old	83-year-old	NN	I-NP	O
with	with	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
medically	medically	RB	B-NP	O
managed	manage	VBN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
change	change	NN	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
and	and	CC	O	O
fall	fall	VB	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
weakness	weakness	NN	B-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
UTI	UTI	NN	I-NP	B-DNA
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
likely	likely	RB	B-ADJP	O
the	the	DT	B-NP	O
reason	reason	NN	I-NP	O
for	for	IN	B-PP	O
confusion	confusion	NN	B-NP	O
and	and	CC	I-NP	O
weakness	weakness	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
ciprofloxacin	ciprofloxacin	NN	B-NP	O
.	.	.	O	O

Urine	Urine	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
and	and	CC	O	O
grew	grow	VBD	B-VP	O
Klebsiella	Klebsiella	NNP	B-NP	O
and	and	CC	I-NP	O
Citrobacter	Citrobacter	NNP	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
indeed	indeed	RB	B-ADVP	O
sensitive	sensitive	JJ	B-ADJP	O
to	to	TO	B-PP	O
ciprofloxacin	ciprofloxacin	NN	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
Ischemia	Ischemia	NNP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
troponin	troponin	NN	I-NP	O
leak	leak	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
of	of	IN	B-PP	O
0.2	0.2	CD	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
B	B	NN	I-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
,	,	,	O	O
the	the	DT	B-NP	O
troponin	troponin	NN	I-NP	O
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
assay	assay	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
leak	leak	NN	I-NP	O
was	be	VBD	B-VP	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-VP	O
demand	demand	VB	I-VP	O
ischemia	ischemia	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
C	C	NN	I-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	B-protein
cardiac	cardiac	JJ	I-NP	I-protein
enzymes	enzyme	NNS	I-NP	I-protein
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
heparin	heparin	NN	I-NP	O
was	be	VBD	B-VP	O
therefore	therefore	RB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
a	a	DT	B-NP	O
candidate	candidate	NN	I-NP	O
for	for	IN	B-PP	O
catheterization	catheterization	NN	B-NP	O
per	per	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
's	's	POS	B-NP	O
notes	note	NNS	I-NP	O
.	.	.	O	O

In-house	In-house	NNP	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
from	from	IN	B-PP	O
Lopressor	Lopressor	NN	B-NP	O
to	to	TO	B-PP	O
labetalol	labetalol	NN	B-NP	O
for	for	IN	B-PP	O
alpha	alpha	NN	B-NP	O
blocking	blocking	NN	I-NP	O
activity	activity	NN	I-NP	O
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
remained	remain	VBD	B-VP	O
high	high	JJ	B-NP	O
and	and	CC	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
optimization	optimization	NN	I-NP	O
was	be	VBD	B-VP	O
attempted	attempt	VBN	I-VP	O
.	.	.	O	O

Norvasc	Norvasc	NN	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
and	and	CC	I-NP	O
hydralazine	hydralazine	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
p.r.n.	p.r.n.	NN	B-NP	O
for	for	IN	B-PP	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
140	140	CD	B-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
doses	dose	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
lisinopril	lisinopril	NN	B-NP	O
and	and	CC	I-NP	O
Diovan	Diovan	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
only	only	JJ	I-NP	O
event	event	NN	I-NP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
being	be	VBG	B-VP	O
a	a	DT	B-NP	O
short	short	JJ	I-NP	O
run	run	NN	I-NP	O
of	of	IN	B-PP	O
SVT	SVT	NN	B-NP	B-protein
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
was	be	VBD	B-VP	O
likely	likely	RB	B-ADJP	O
related	relate	VBN	I-ADJP	O
to	to	TO	B-PP	O
urinary	urinary	JJ	B-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
head	head	NN	I-NP	O
CT	CT	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
neuro	neuro	NN	I-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
suggestive	suggestive	JJ	B-ADJP	O
of	of	IN	B-PP	O
any	any	DT	B-NP	O
focal	focal	JJ	I-NP	O
deficits	deficit	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
Detrol	Detrol	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
its	its	PRP$	B-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
weakness	weakness	NN	I-NP	O
was	be	VBD	B-VP	O
likely	likely	RB	B-ADJP	O
due	due	IN	B-PP	O
to	to	TO	I-PP	O
deconditioning	deconditioning	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
very	very	RB	B-ADJP	O
weak	weak	JJ	I-ADJP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
trouble	trouble	NN	B-NP	O
sitting	sit	VBG	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
edge	edge	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bed	bed	NN	I-NP	O
or	or	CC	O	O
transferring	transfer	VBG	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
chair	chair	NN	I-NP	O
with	with	IN	B-PP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
who	who	WP	B-NP	O
recommended	recommend	VBD	B-VP	O
rehabilitation	rehabilitation	NN	B-NP	O
and	and	CC	O	O
24-hour	24-hour	JJ	B-NP	O
supervision	supervision	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
family	family	NN	I-NP	O
refused	refuse	VBD	B-VP	O
transfer	transfer	NN	B-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
Skilled	Skilled	JJ	I-NP	O
Nursing	Nursing	NN	I-NP	O
Facility	Facility	NN	I-NP	O
despite	despite	IN	B-PP	O
the	the	DT	B-NP	O
recommendation	recommendation	NN	I-NP	O
and	and	CC	O	O
they	they	PRP	B-NP	O
understood	understand	VBD	B-VP	O
the	the	DT	B-NP	O
concern	concern	NN	I-NP	O
and	and	CC	I-NP	O
risks	risk	NNS	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
reportedly	reportedly	RB	B-ADVP	O
planned	plan	VBD	B-VP	O
to	to	TO	I-VP	O
supervise	supervise	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
on	on	IN	B-PP	O
their	their	PRP$	B-NP	O
own	own	JJ	I-NP	O
,	,	,	O	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
everyday	everyday	JJ	B-ADJP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
diabetes	diabete	NNS	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
were	be	VBD	B-VP	O
low	low	JJ	B-ADJP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Originally	Originally	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
NPH	NPH	NN	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
cut	cut	VBN	I-VP	O
in	in	IN	B-PP	O
half	half	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
were	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
and	and	CC	O	O
remained	remain	VBN	B-VP	O
quite	quite	RB	B-ADJP	O
low	low	JJ	I-ADJP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
evening	evening	NN	I-NP	O
NPH	NPH	NN	I-NP	O
was	be	VBD	B-VP	O
halved	halve	VBN	I-VP	O
again	again	RB	B-ADVP	O
to	to	TO	B-PP	O
5	5	CD	B-NP	O
units	unit	NNS	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
appetite	appetite	NN	I-NP	O
remained	remain	VBD	B-VP	O
fair	fair	JJ	B-ADJP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	B-ADJP	O
great	great	JJ	I-ADJP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
Lovenox	Lovenox	NNP	B-NP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
DNR/DNI	DNR/DNI	NN	B-NP	O
was	be	VBD	B-VP	O
instituted	institute	VBN	I-VP	O
after	after	IN	B-PP	O
lengthy	lengthy	JJ	B-NP	O
discussions	discussion	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
family	family	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
INSTRUCTIONS	INSTRUCTIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

See	See	VB	B-VP	O
the	the	DT	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
within	within	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Discuss	Discuss	VB	B-VP	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
when	when	WRB	B-ADVP	O
and	and	CC	O	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
should	should	MD	B-VP	O
resume	resume	VB	I-VP	O
Detrol	Detrol	NNP	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Return	Return	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
experience	experience	VBP	B-VP	O
fevers	fever	NNS	B-NP	O
,	,	,	O	O
worsening	worsen	VBG	B-VP	O
confusion	confusion	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
other	other	JJ	B-NP	O
concerns	concern	NNS	I-NP	O
.	.	.	O	O

DIET	DIET	NN	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
restrictions	restriction	NNS	I-NP	O
.	.	.	O	O

ACTIVITY	ACTIVITY	NN	B-NP	O
:	:	:	O	O
Bed	Bed	VBN	B-VP	O
to	to	TO	I-VP	O
chair	chair	VB	I-VP	O
transfers	transfer	NNS	B-NP	O
with	with	IN	B-PP	O
assistance	assistance	NN	B-NP	O
and	and	CC	I-NP	O
supervision	supervision	NN	I-NP	O
and	and	CC	O	O
other	other	JJ	B-NP	O
instructions	instruction	NNS	I-NP	O
per	per	IN	B-PP	O
home	home	NN	B-NP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

PRINCIPAL	PRINCIPAL	JJ	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Urinary	Urinary	JJ	B-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

OTHER	OTHER	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
Hypertension	Hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
hemorrhoids	hemorrhoid	NNS	B-NP	O
,	,	,	O	O
depression	depression	NN	B-NP	O
,	,	,	O	O
hyperparathyroidism	hyperparathyroidism	NN	B-NP	O
,	,	,	O	O
multinodular	multinodular	JJ	B-NP	O
goiter	goiter	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
Glucose	Glucose	NN	B-NP	B-protein
160	160	CD	I-NP	I-protein
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
12	12	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
0.9	0.9	CD	I-NP	O
,	,	,	O	O
sodium	sodium	NN	B-NP	O
141	141	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.1	4.1	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
112	112	CD	I-NP	O
,	,	,	O	O
CO2	CO2	NN	B-NP	O
23	23	CD	I-NP	O
,	,	,	O	O
ALT	ALT	NN	B-NP	B-DNA
32	32	CD	I-NP	I-DNA
,	,	,	O	O
AST	AST	NN	B-NP	O
29	29	CD	I-NP	O
,	,	,	O	O
ALK	ALK	NN	B-NP	B-DNA
68	68	CD	I-NP	I-DNA
,	,	,	O	O
bili	bili	JJ	B-NP	O
T	T	NN	I-NP	O
0.5	0.5	CD	I-NP	O
.	.	.	O	O

Albumin	Albumin	NNP	B-NP	O
3.4	3.4	CD	I-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	B-protein
10.6	10.6	CD	I-NP	I-protein
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
2.0	2.0	CD	I-NP	O
,	,	,	O	O
white	white	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
6.9	6.9	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
36.9	36.9	CD	I-NP	I-protein
,	,	,	O	O
hemoglobin	hemoglobin	NN	B-NP	B-protein
11.4	11.4	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
233	233	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
,	,	,	O	O
PTT	PTT	NN	B-NP	B-protein
37.4	37.4	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
INR	INR	NN	B-NP	B-protein
1.1	1.1	CD	I-NP	I-protein
.	.	.	O	O

MICROBIOLOGY	MICROBIOLOGY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Urine	Urine	NN	B-NP	O
showed	show	VBD	B-VP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
100	100	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
,	,	,	I-NP	O
4	4	CD	I-NP	O
+	+	SYM	I-NP	O
Klebsiella	Klebsiella	NNP	I-NP	O
pneumoniae	pneumoniae	FW	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
4	4	CD	B-NP	O
+	+	SYM	I-NP	O
Citrobacter	Citrobacter	NNP	I-NP	O
freundii	freundii	NNS	I-NP	O
.	.	.	O	O

RADIOGRAPHIC	RADIOGRAPHIC	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
portable	portable	JJ	I-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
on	on	IN	B-PP	O
1/13/05	1/13/05	CD	B-NP	O
,	,	,	O	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
middle	middle	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
mass	mass	NN	I-NP	O
,	,	,	O	O
unchanged	unchanged	JJ	B-ADJP	O
in	in	IN	B-PP	O
comparison	comparison	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
prior	prior	JJ	I-NP	O
exam	exam	NN	I-NP	O
corresponding	correspond	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
known	known	JJ	I-NP	O
carcinoid	carcinoid	JJ	I-NP	O
tumor	tumor	NN	I-NP	O
,	,	,	O	O
known	know	VBN	B-VP	O
pulmonary	pulmonary	JJ	B-NP	O
infiltrates	infiltrate	NNS	I-NP	O
or	or	CC	O	O
pleural	pleural	JJ	B-NP	O
effusion	effusion	NN	I-NP	O
.	.	.	O	O

Head	Head	JJ	B-NP	O
CT	CT	NN	I-NP	O
on	on	IN	B-PP	O
1/13/05	1/13/05	CD	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
intracranial	intracranial	JJ	I-NP	O
process	process	NN	I-NP	O
and	and	CC	O	O
widespread	widespread	JJ	B-NP	O
degenerative	degenerative	JJ	I-NP	O
disease	disease	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cervical	cervical	JJ	I-NP	O
spine	spine	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
for	for	IN	B-PP	O
fracture	fracture	NN	B-NP	O
or	or	CC	I-NP	O
dislocation	dislocation	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
EKG	EKG	NN	I-NP	B-protein
on	on	IN	B-PP	O
2/29/05	2/29/05	CD	B-NP	O
had	have	VBD	B-VP	O
ventricular	ventricular	JJ	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
5	5	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
PR	PR	NN	I-NP	B-protein
interval	interval	NN	I-NP	O
of	of	IN	B-PP	O
164	164	CD	B-NP	O
,	,	,	O	O
QRS	QRS	NNP	B-NP	O
duration	duration	NN	I-NP	O
of	of	IN	B-PP	O
78	78	CD	B-NP	O
,	,	,	O	O
showed	show	VBD	B-VP	O
sinus	sinus	NN	B-NP	O
bradycardia	bradycardia	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
ventricular	ventricular	JJ	B-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
with	with	IN	B-PP	O
repolarization	repolarization	NN	B-NP	O
abnormality	abnormality	NN	I-NP	O
,	,	,	O	O
ST	ST	NN	B-NP	O
and	and	CC	I-NP	O
T-wave	T-wave	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
EKG	EKG	NN	B-NP	B-protein
of	of	IN	B-PP	O
1/13/05	1/13/05	CD	B-NP	O
T-wave	T-wave	NN	I-NP	O
abnormality	abnormality	NN	I-NP	O
of	of	IN	B-PP	O
inferior	inferior	JJ	B-NP	O
lead	lead	NN	I-NP	O
placement	placement	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
UPON	UPON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
Enteric-coated	Enteric-coated	JJ	B-NP	O
aspirin	aspirin	NN	I-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
ciprofloxacin	ciprofloxacin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
12	12	CD	I-NP	O
h.	h.	NN	I-NP	O
for	for	IN	B-PP	O
three	three	CD	B-NP	O
more	more	JJR	I-NP	O
days	day	NNS	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
seven	seven	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
NPH	NPH	NN	I-NP	I-protein
human	human	JJ	I-NP	I-protein
10	10	CD	I-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-ADVP	O
q.a.m.	q.a.m.	RB	B-ADVP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
NPH	NPH	NN	I-NP	I-protein
human	human	JJ	I-NP	I-protein
5	5	CD	I-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-ADVP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
,	,	,	O	O
labetalol	labetalol	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
nitroglycerin	nitroglycerin	NN	B-NP	O
tablets	tablet	NNS	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
Tucks	Tuck	VBZ	B-VP	O
topical	topical	JJ	B-NP	O
PR	PR	NN	I-NP	B-protein
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
amlodipine	amlodipine	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Fosamax	Fosamax	NN	B-NP	B-protein
70	70	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	FW	I-NP	I-protein
every	every	DT	B-NP	I-protein
week	week	NN	I-NP	I-protein
,	,	,	O	O
Diovan	Diovan	NNP	B-NP	O
320	320	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Wellbutrin	Wellbutrin	NNP	B-NP	O
SR	SR	NNP	I-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
Lipitor	Lipitor	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
5-8301196	5-8301196	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
LENOCI	LENOCI	NNP	B-NP	O
,	,	,	O	O
HORACIO	HORACIO	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
WERNTZ	WERNTZ	NNP	B-NP	O
,	,	,	O	O
EARNEST	EARNEST	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
2895456	2895456	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
2/27/05	2/27/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
2/27/05	2/27/05	CD	B-NP	O

